Manlio Fusciello
Impact in
- Immunology top 10%
- Immunotherapy and Immune Responses
- Oncology top 10%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
- Immunology 18
- Immunotherapy and Immune Responses 18
- Phagocytosis and Immune Regulation 2
- Oncology 17
- CAR-T cell therapy research 15
- Cancer Immunotherapy and Biomarkers 4
- Co-authors
- Vincenzo Cerullo (24 shared papers)Sara Feola (19 shared papers)Erkko Ylösmäki (14 shared papers)Beatriz Martins (13 shared papers)Cristian Capasso (8 shared papers)Jacopo Chiaro (12 shared papers)Firas Hamdan (13 shared papers)Karita Peltonen (7 shared papers)
- Journals
- Molecular Therapy — Oncolytics (3 papers)OncoImmunology (3 papers)Journal for ImmunoTherapy of Cancer (3 papers)Cancer Immunology Research (3 papers)PLoS ONE (2 papers)
- Partner nations
- FinlandItalyNetherlands
In The Last Decade
Manlio Fusciello
25 papers receiving 560 citations
Peers
Comparison fields: 5 of 66
- Immunology 236
- Oncology 264
- Biotechnology 67
- Genetics 183
- Biomaterials 52
Countries citing papers authored by Manlio Fusciello
This map shows the geographic impact of Manlio Fusciello's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manlio Fusciello with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manlio Fusciello more than expected).
Fields of papers citing papers by Manlio Fusciello
This network shows the impact of papers produced by Manlio Fusciello. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manlio Fusciello. The network helps show where Manlio Fusciello may publish in the future.
Co-authors
The 25 scholars most cited alongside Manlio Fusciello, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 97 | |
| 2 | 2019 | 52 | |
| 3 | 2019 | 40 | |
| 4 | 2018 | 40 | |
| 5 | 2020 | 40 | |
| 6 | 2018 | 39 | |
| 7 | 2021 | 37 | |
| 8 | 2016 | 29 | |
| 9 | 2022 | 26 | |
| 10 | 2021 | 25 | |
| 11 | 2017 | 23 | |
| 12 | 2021 | 22 | |
| 13 | 2019 | 17 | |
| 14 | 2021 | 15 | |
| 15 | 2022 | 14 | |
| 16 | 2024 | 8 | |
| 17 | 2021 | 8 | |
| 18 | 2024 | 7 | |
| 19 | 2019 | 7 | |
| 20 | 2024 | 6 |
About Manlio Fusciello
Manlio Fusciello is a scholar working on Immunology, Oncology, Genetics, Molecular Biology and Surgery, having authored 25 papers that have together received 564 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (18 papers), CAR-T cell therapy research (15 papers), Virus-based gene therapy research (11 papers), vaccines and immunoinformatics approaches (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), RNA Interference and Gene Delivery (3 papers), Phagocytosis and Immune Regulation (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). The work is most often cited by research in Immunology (236 citations), Oncology (264 citations), Biotechnology (67 citations), Genetics (183 citations) and Biomaterials (52 citations). Manlio Fusciello has collaborated with scholars based in Finland, Italy and Netherlands. Frequent co-authors include Vincenzo Cerullo, Sara Feola, Erkko Ylösmäki, Beatriz Martins, Cristian Capasso, Jacopo Chiaro, Firas Hamdan, Karita Peltonen, Jouni Hirvonen and Hélder A. Santos. Their work appears in journals such as Molecular Therapy — Oncolytics, OncoImmunology, Journal for ImmunoTherapy of Cancer, Cancer Immunology Research and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.